He Chen Phones & Addresses
-
Flushing, NY
-
Butler, PA
-
Kittanning, PA
-
Edison, NJ
-
New York, NY
Business Records
Name / Title
Company / Classification
Phones & Addresses
RUI FENG CORP
90-07 Corona Ave, Elmhurst, NY 11373
WENG IRON CORP
51 Chrystie St, New York, NY 10002
TIAN HUI CORP
90-07 Corona Ave, Elmhurst, NY 11373
EMPIRE OREGON RESTAURANT LLC
Principal
New Kam Fung Inc
Eating Place · Eating Places · Nonclassifiable Establishments
Eating Place · Eating Places · Nonclassifiable Establishments
210 Hamilton St, New Brunswick, NJ 08901
Publications
Isbn (Books And Publications)
Lun Guo Ji Huan Jing Jing Ji Guan Xi
View page
Author
He Chen
ISBN #
7807073284
Us Patents
Heterobifunctional Compounds As Degraders Of Hpk1
View pageUS Patent:
20230022524, Jan 26, 2023
Filed:
May 5, 2020
Appl. No.:
17/604636
Inventors:
- New York NY, US
Steven Burakoff - New York NY, US
H. Umit Kaniskan - New York NY, US
Sansana Sawasdikosol - New York NY, US
He Chen - New York NY, US
Joshua Brody - New York US, US
Nina Bhardwaj - New York NY, US
Steven Burakoff - New York NY, US
H. Umit Kaniskan - New York NY, US
Sansana Sawasdikosol - New York NY, US
He Chen - New York NY, US
Joshua Brody - New York US, US
Nina Bhardwaj - New York NY, US
International Classification:
A61K 47/55
A61K 39/395
A61K 47/54
A61P 35/00
A61K 39/395
A61K 47/54
A61P 35/00
Abstract:
Disclosed are Hematopoietic Progenitor Kinase 1 (HPK1) degradation/disruption compounds including a HPK1 ligand, a degradation/disruption tag and a linker, and methods for use of such compounds in the treatment of HPK1-mediated diseases.
Compositions And Methods For Treating Alk-Mediated Cancer
View pageUS Patent:
20210283261, Sep 16, 2021
Filed:
Dec 4, 2018
Appl. No.:
16/769326
Inventors:
- New york NY, US
- Chapel Hill NC, US
Jing Liu - New York NY, US
Chengwei Zhang - New York NY, US
Xiaoran Han - Chapel Hill NC, US
He Chen - New York NY, US
Pu Wang - Chapel Hill NC, US
- Chapel Hill NC, US
Jing Liu - New York NY, US
Chengwei Zhang - New York NY, US
Xiaoran Han - Chapel Hill NC, US
He Chen - New York NY, US
Pu Wang - Chapel Hill NC, US
International Classification:
A61K 47/54
A61K 31/506
C07D 401/14
C07D 417/14
G01N 33/50
A61K 31/506
C07D 401/14
C07D 417/14
G01N 33/50
Abstract:
Heterobifunctional small molecules including anaplastic lymphoma kinase (ALK) ligand conjugated to a degradation/disruption tag through a linker, which selectively degrade/disrupt ALK, ALK fusion proteins, and/or ALK mutant proteins, and compositions and methods of using such degraders/disruptors to treat ALK-mediated cancer are provided.